Hemodynamic theory of progressive renal disease: a 10-year update in brief review.
Experimental studies have suggested that glomerular hypertension is ultimately damaging to the kidney. Prevention of glomerular hypertension by dietary protein restriction or antihypertensive therapy lessens glomerular injury in several experimental models of chronic renal disease. Glomerular hypertension and hyperfiltration also occur in humans with diabetes mellitus, solitary or remnant kidneys, and various forms of acquired renal disease. Clinical studies are beginning to show that dietary protein restriction and antihypertensive therapy may slow progression in these disorders. Large multicenter trials are currently under way to better define the effects of these therapeutic maneuvers on the progression of chronic renal disease.
Neuringer
J R
JR
Renal Division, Brigham and Women's Hospital, Boston, MA 02115.
Brenner
B M
BM
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004044:Dietary Proteins / Q000008:administration & dosage; D005919:Glomerular Filtration Rate; D006439:Hemodynamics; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000503:physiopathology / Q000517:prevention & control; D007678:Kidney Glomerulus / Q000503:physiopathology; D051381:Rats
D000959:Antihypertensive Agents; D004044:Dietary Proteins